TrialScientific reports2025

Safety and efficacy of one-dose nocturnal levetiracetam for the treatment of self-limited epilepsy with centrotemporal spikes: a randomized clinical trial.

Lijuan Fan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.